BT Industry Created Triangular Axis of 'Conglomerate, Pharmaceutical Manufacturer and Venture'

Published: 2002-01-17 06:59:00

Updated: 2002-01-17 06:59:00

It is expected that capacity will be collected for infra construction this year while conglomerate, pharmaceutical manufacturer, and bio-venture create triangular axis respectively in the local biology technology (BT) world this year.

Conglomerate pointed out biology technology as NO.1 new bus...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK